Molecular modeling on medicinal chemistry education
暂无分享,去创建一个
Gustavo Henrique Goulart Trossini | Elizabeth Igne Ferreira | Carolina Horta Andrade | C. Andrade | E. Ferreira | G. Trossini
[1] P. Tonge,et al. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway. , 2008, Accounts of chemical research.
[2] Carolina Horta Andrade,et al. Abordagem racional no planejamento de novos tuberculostáticos: inibidores da InhA, enoil-ACP redutase do M. tuberculosis , 2008 .
[3] C. Wermuth,et al. Comprar The Practice of Medicinal Chemistry, 3rd Edition | Camille G. Wermuth | 9780123741943 | Academic Press , 2009 .
[4] K. Chou,et al. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus. , 2009, Biochemical and biophysical research communications.
[5] L. Sternbach. The benzodiazepine story. , 1983, Journal of psychoactive drugs.
[6] J. Sacchettini,et al. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. , 1998, Science.
[7] Alessandro Pedretti,et al. VEGA: a versatile program to convert, handle and visualize molecular structure on Windows-based PCs. , 2002, Journal of molecular graphics & modelling.
[8] P. Emery,et al. Cyclooxygenase-2: a major therapeutic advance? , 2001, The American journal of medicine.
[9] W. Delano. The PyMOL Molecular Graphics System , 2002 .
[10] Garret A. FitzGerald,et al. COX-2 and beyond: approaches to prostaglandin inhibition in human disease , 2003, Nature Reviews Drug Discovery.
[11] Paolo Tortorella,et al. An Introduction to Medicinal Chemistry 4th ed. , 2010 .
[12] Peter J Tonge,et al. High affinity InhA inhibitors with activity against drug-resistant strains of Mycobacterium tuberculosis. , 2006, ACS chemical biology.
[13] N. Claude Cohen,et al. Guidebook on molecular modeling in drug design , 1996 .
[14] C. Vilchèze,et al. Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid , 2006, Nature Medicine.
[15] W. Foye,et al. Foye's Principles of Medicinal Chemistry , 2002 .
[16] Alan J. Hay,et al. Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants , 2008, Nature.
[17] I. Carvalho,et al. Medicinal Chemistry and Molecular Modeling: An Integration To Teach Drug Structure-Activity Relationship and the Molecular Basis of Drug Action , 2005 .